APOE and Cognitive impairment: While there is evidence linking ApoE4 to cognitive deficits, morphological, structural, and functional brain alterations during AD progression (Cherbuin et al., 2007; Liu et al., 2013), at this point, it is still unclear how this genetic risk factor affects the organization of brain networks.